β-actin plays key roles in cell migration. Our previous work demonstrated that β-actin in migratory non-muscle cells is N-terminally arginylated and that this arginylation is required for normal lamellipodia extension. Here, we examined the function of β-actin arginylation in cell migration. We found that arginylated β-actin is concentrated at the leading edge of lamellipodia and that this enrichment is abolished after serum starvation as well as in contact-inhibited cells in confluent cultures, suggesting that arginylated β-actin at the cell leading edge is coupled to active migration. Arginylated actin levels exhibit dynamic changes in response to cell stimuli, lowered after serum starvation and dramatically elevating within minutes after cell stimulation by readdition of serum or lysophosphatidic acid. These dynamic changes require active translation and are not seen in confluent contact-inhibited cell cultures. Microinjection of arginylated actin antibodies into cells severely and specifically inhibits their migration rates. Together, these data strongly suggest that arginylation of β-actin is a tightly regulated dynamic process that occurs at the leading edge of locomoting cells in response to stimuli and is integral to the signaling network that regulates cell migration. In our previous work, we found that β-actin, unlike other actin isoforms, undergoes N-terminal arginylation mediated by arginyltransferase Ate1. 3 This arginylation is tightly co-translationally regulated via unique features of β-actin coding sequence that set it apart from the closely related equally abundant nonmuscle γ-actin, which is not N-terminally arginylated. 4 Lack of arginylation leads to impairments in lamellipodia formation and cell migration, 3,5 the effects that can be at least partially rescued by expression of arginylated actin in cells; however, the exact contribution of actin arginylation to the arginylation-dependent impairments in cell migration are unknown.
| INTRODUCTION
β-actin is an essential, ubiquitously expressed protein and the major constituent of the actin cytoskeleton in migratory cell types. During cell migration, actin interacts with multiple proteins 1 and undergoes a number of posttranslational modifications; 2 however, the underlying regulatory mechanisms that drive cell migration and control actin dynamics at the cell leading edge are not fully understood.
In our previous work, we found that β-actin, unlike other actin isoforms, undergoes N-terminal arginylation mediated by arginyltransferase Ate1. 3 This arginylation is tightly co-translationally regulated via unique features of β-actin coding sequence that set it apart from the closely related equally abundant nonmuscle γ-actin, which is not N-terminally arginylated. 4 Lack of arginylation leads to impairments in lamellipodia formation and cell migration, 3, 5 the effects that can be at least partially rescued by expression of arginylated actin in cells; however, the exact contribution of actin arginylation to the arginylation-dependent impairments in cell migration are unknown.
Moreover, it has never been studied whether actin arginylation in cells is segregated into a specific cell area or a subset of the total actin pool, and whether it represents a stationary mark or a dynamic modification that can mediate cell responses to stimuli.
Here we used a newly developed arginylated β-actin antibody to address these questions and analyze the distribution and dynamics of actin arginylation during cell migration. Our results indicate that arginylation represents a dynamic actin modification that likely mediates cellular responses to migratory stimuli at the cell leading edge.
2 | RESULTS
| Arginylated β-actin localizes to the leading edge of migrating cells
Previous studies of actin arginylation in cells have been difficult, due to the lack of the available tools that would enable reliable detection of endogenous arginylated actin in cells. Development of specific arginylation antibodies has been generally challenging due to the fact that the posttranslationally added Arg is too similar to the Arg natively present in multiple proteins in vivo. However, recently, EMD Millipore has successfully raised new polyclonal peptide antibodies against N-terminally arginylated β-actin (ABT264). We used these antibodies to characterize β-actin arginylation in cells. The specific batch of antibodies used for this project selectively recognize baculovirus-expressed N-terminally arginylated actin and do not cross-react with β-actin lacking N-terminal arginylation (R-and Mactin, respectively, Figure 1A ), even though they still retain some residual cross-reactivity with an actin-sized band in arginylation deficient cell extracts (prepared from mouse embryonic fibroblasts
[MEFs] with knockout of arginyltransferase Ate1 as described in Reference   3 ) ( Figure 1B) . Moreover, these antibodies pull down a residual band from Ate1 knockout cell extracts that shows cross-reactivity with pan-actin antibodies but not with the β-actin antibodies ( Figure 1C ).
We first tested the overall distribution of arginylated β-actin (Ractin) in migratory MEFs using non-detergent cell extraction with acetone (as described, eg, in 6 ). This staining revealed a narrow zone at the very edge of the lamellipodia (Figure 2A , top right and 2B, top left), in addition to the diffuse perinuclear staining that did not appear to coincide with the majority of the actin filament distribution in that area. Notably, this leading edge R-actin staining disappeared after cell extraction with Triton X-100 ( Figure 2A , bottom right), while being retained after methanol fixation ( Figure 2B , bottom left) suggesting that R-actin localization at the cell leading edge is detergent labile.
Notably, residual staining in these regions, as well as faint leading edge staining, could also be seen in some of the Ate1 knockout cells Figure 2B , right panels). While this staining was considerably weaker in these cells (as seen by comparison left and right panels in Figure 2B , which have been scaled to the same intensity levels), in combination with the western blot results shown in Figure 1 this result suggest that residual level of arginylated β-actin may still be retained in these cells.
To test whether the staining at the edge of the lamellipodia region correlates with active migration, we stained cells at the edge of the scratch wound, where the lamellipodia facing outward into the wound areas are formed by the cells that are actively locomoting, while other lamellipodia-like structures inward to the edge of the monolayer can be transiently contact-inhibited and not undergoing active migration ( Figure 2C ). R-actin staining was prominently seen at the edge of the lamellipodia facing the wound, while being absent in the "inward" regions where cells were facing each other and thus were unlikely to migrate in that direction (an example is indicated by arrow in Figure 2C ), suggesting that R-actin leading edge localization likely coincides with active migration.
Given that this leading edge R-actin staining is detergent-labile, it is possible that it preferentially targets actin monomers or short oligomers that can be washed out after Triton X-100 extraction. To test this, we performed differential fractionation of cell extracts by sequential centrifugation and tested the presence of R-actin in the supernatant and pellet from each step by western blotting ( Figure 2D ). In this experiment, R-actin appeared to be uniformly distributed in the G-and F-actin pool, similar to the distribution of β-actin and total actin. Thus, the overall R-actin reactivity does not appear to be biased to either actin polymer or monomer. However, it is still possible that the detergent-labile zone at the edge of the cells represents a pool of monomeric/oligomeric R-actin.
2.2 | Arginylated β-actin enrichment at the leading edge is diminished after serum starvation
Our previous work showed that arginylated actin facilitates cell leading edge formation during migration. 3 To test if β-actin arginylation correlates with the cells' active migratory state, we used serum starvation, a treatment that inhibits cell migration and places cells into quiescent state without strongly affecting their overall morphology or lamellipodial activity (Videos S1-S4, Supporting information). We then compared the R-actin staining in cells before and after serum starvation.
While virtually every cell grown in normal serum at low density before dropping to approximate pre-starvation levels after 24 hours.
As a control experiment, we used similarly treated 100% confluent cells that undergo quiescence upon serum starvation, but cannot initiate migration after serum stimulation, due to confluency-dependent contact inhibition. In these cells, arginylated actin levels did not reduce after serum starvation and did not significantly increase after stimulation, confirming that the dynamics of arginylated actin levels in response to stimulation likely depends on active migration rather than on other metabolic changes in response to serum treatment ( Figure S1 ).
To confirm that this R-actin response is mediated via cell migration stimuli and not any other serum components, we performed a similar experiment using cell stimulation in low serum media by addition of lysophosphatidic acid (LPA), which stimulates cell migration via modulation of G-protein signaling [8] [9] [10] but does not alter the balance of nutrients or overall composition of the cell culture media.
Addition of LPA to serum-starved cells under low serum conditions induced a rapid increase in R-actin levels that changed over time similarly to the serum stimulation experiment ( Figure 3C ), suggesting that this R-actin response was indeed linked to cell migratory stimuli.
Thus, actin arginylation is a dynamic event that exhibits a rapid response to cell stimulation to migrate and is regulated over time.
| Dynamic changes in actin arginylation require active protein synthesis
We have previously found that β-actin arginylation is coupled to its translation rate and co-translational arginylation-dependent degradation. 4 Our
Characterization of arginylated actin (R-actin) antibodies. A, Baculovirus-expressed non-arginylated and N-terminally arginylated actin (M-and R-actin, respectively) fractionated on the SDS gel next to wild type cell lysate (WT lysate), Coomassie-stained (left) and probed with antibodies to R-actin (middle) and β-actin (right). B, Diluted lysates from wild type (WT) and Ate1 knockout (KO) cells probed with the antibodies to arginyltransferase Ate1, R-actin, and pan-actin. R-actin antibodies recognize a residual actin-sized band in KO cells, which can be titered out by dilution. C, Immunoprecipitates from WT and KO cells using R-actin antibodies. A~43 kDa actin band is prominent in WT precipitates and also faintly visible in the KO. This band is faintly recognized by the R-actin and pan-actin, but not the beta actin antibodies. Arrow indicates the level at which the membrane was cut to eliminate the IgG heavy chain band and enable the detection of the actin bands without the secondary antibody background prior work also showed that a subset of Ate1 in the cell is associated with the ribosomes, potentially making it available to participate in cotranslational arginylation. 11 It has been previously found that β-actin mRNA is transported to the cell leading edge, where it is likely translated on the spot to facilitate cell migration. 12 Notably, sequence analysis of Ate1 mRNA also reveals a putative zipcode-binding leading edge targeting signal, suggesting that β-actin and Ate1 mRNA can potentially colocalize at the cell leading edge where their simultaneous translation may facilitate β-actin arginylation. To test this hypothesis, we used fluorescence in situ hybridization (FISH) to localize the β-actin and Ate1 mRNA FIGURE 2 R-actin antibodies show prominent reactivity within a narrow detergent-labile zone at the edge of the lamellipodia. A, Immunofluorescence staining of mouse embryonic fibroblasts grown in normal serum conditions using phalloidin (F-actin) and R-actin antibodies with acetone (top) or detergent (bottom) extraction. Acetone-extracted cells show prominent antibody reactivity with a narrow zone at the leading edge, absent after Triton X100 extraction. B, Immunofluorescence staining of acetone (top) and methanol (bottom) extracted wild type (WT) and Ate1 knockout (KO) cells using R-actin antibodies. Images are scaled to equal gray levels to enable direct comparison of the staining in WT and KO cells. C, R-actin staining (top) and phase contrast (bottom) images of WT cells migrating into the scratch wound. The cell edges facing the wound exhibit prominent leading edge staining, while the cell edges facing away from the wound and partially contact-inhibited (indicated by arrow in the bottom image) show no such leading edge enrichment. A-C scale bars, 20 μm. D, western blots of whole cell lysates fractionated by differential centrifugation steps (identified by g-force on the top) to reveal actin distribution between monomeric and polymeric fraction. S, supernatant, P, pellet in migratory wild type fibroblasts ( Figure 4A ). These tests revealed that a subset of both β-actin and Ate1 mRNA localized to the cell periphery, consistent with the idea that both of these mRNAs are targeted there by specific mechanisms involving long-range mRNA transport. However, the FISH signals for these 2 mRNAs failed to co-localize in the same spots, suggesting that the majority of β-actin and Ate1 are unlikely to undergo simultaneous translation. It is still possible, however, that leading edgesynthesized Ate1 associates with the ribosomes and aginylates the newly synthesized actin.
To test this possibility and determine whether the changes in Ractin seen after serum/LPA stimulation require active protein synthesis, we performed serum stimulation experiments similar to those shown in Figure 3 in the presence of translation inhibitor cycloheximide ( Figure 4B ). This treatment completely abolished the dynamic changes in actin arginylation levels seen in serum-stimulated cells, confirming that these changes require active translation.
| Inhibition of actin arginylation inhibits cell migration
To directly test the effect of R-actin inhibition on cell migration, we used scarce cells, grown in normal serum to exhibit random migration As a control, we injected both cells with antibodies to β-actin, taken at the same concentration. In wild type cells, this injection inhibited cell migration ( Figure S2 ), consistent with prior findings that β-actin is essential for cell migration. 13 Notably, however, the inhibition seen after this injection was not as severe as that seen after injection of R-actin antibodies, consistent with the fact that β-actin antibody likely acts by somewhat reducing the overall β-actin pool rather than by specifically targeting an essential cell migration component. Injection of Ate1 knockout cells with β-actin antibodies produced a negligible effect ( Figure S2 ). This is likely due to the fact that these cells have a dramatic reduction in the actin polymer: monomer ratio, 14 and thus sequestering some of this extra actin monomer pool does not have a strong effect on the overall actin polymerization, which is required for cell migration. Thus, arginylated actin is required for maintaining normal cell migration.
| DISCUSSION
This study demonstrates for the first time that arginylation of β-actin is a dynamic posttranslational modification that specifically targets a subset of actin at the cell leading edge and responds to stimuli to maintain cell migration rate and the dynamics of the cell leading edge.
We have previously shown that β-actin is arginylated, and linked this arginylation to the overall morphology of the lamellipodia, 3 however it has been unclear whether actin arginylation is regulated, whether it is confined to any particular area of the cell, and whether it is required for rapid responses to environment during cell movement.
Our current study resolves these questions and demonstrates that actin arginylation can directly and dynamically modulate its in vivo function in cell migration. Our data show that arginylation constitutes a rapid and dynamic response to cell migration stimuli, such as LPA, or serum readdition after starvation, previously shown to stimulate actin polymerization and leading edge activity in the cell. 15 In fact, prominent increase in arginylated actin occurs within minutes of serum addition, suggesting that this modification is highly dynamic. Moreover, R-actin localization to the narrow leading edge zone suggests a specialized mecha- Our data show that stimulation of actin arginylation upon serum addition requires active protein synthesis and does not occur in the presence of translation inhibitor cycloheximide. It has been previously found that arginyltransferase can partially co-localize with the ribosomes, where it presumably has an advantage in utilizing the locally synthesized Arg-tRNA. It has also been shown that β-actin mRNA is partially targeted to the cell leading edge in migrating cells [16] [17] [18] and that serum stimulation leads to an increase in actin synthesis. 15, 19 Our study for the first time combines the results of these findings into a general model, which predicts that cell migration stimuli lead to localized actin arginylation via a mechanism coupled to its de novo synthesis at the cell leading edge. It seems likely that this combined mechanism at least in part underlies the known dependence of cell migration on actin mRNA localization at the leading edge, which may enable the cell to produce a differentiated subset of arginylated actin on the spot. Dissecting this regulatory mechanism, and the underlying mechanics that links actin arginylation to cell movement, constitutes an exciting direction of future studies.
| MATERIALS AND METHODS

| R-actin antibody
Rabbit polyclonal antibody to arginylated β-actin used in this study was developed by EMD Millipore (ABT264). The current work utilizes mostly Batch 13 of the antibody, different from the bulk of the commercially available Batch 15, due to the fact that the former antibody showed better R-actin specificity in the initial tests. We confirmed,
however, that both antibodies show similar staining in cultured cells and have nearly equal reactivity on western blots with wild type cell lysates.
| Cell culture
Wild-type and arginyltransferase 1 (Ate1) KO MEF cell lines were obtained by immortalization of primary cells as described previously. 3 Cell lines stably expressing GFP-β-actin fusion for the fluorescence in Baculovirus expression and purification of arginylated and nonarginylated β-actin for the western blot shown in Figure 1A was performed as described in 21 using mouse M-β and R-β ubiquitin-actin fusion constructs made as described in. 
| Cycloheximide and LPA treatment
For cycloheximide treatment, cells were plated at 30% confluency followed by 24 hours of serum starvation (0.5% serum) and 1 hour pretreatment with 50 μg/mL of cycloheximide. Next, culture media supplemented with 10% of serum, containing 100 μg/mL cycloheximide, was added to each plate and cells were incubated for 
| Random motility assays
Random motility assay was assessed by a time-lapse microscopy as previously described. 22 Cells were seeded onto a MatTek dish, and Cells were stained with DAPI (5 ng/mL) and mounted using Prolong Diamond (Life Technologies). Images were acquired using Nikon Ti inverted microscope equipped with Andor iXon Ultra 897 camera at ×100. FISH images were then processed using Fiji to remove background (rolling ball background subtraction with a radius of 6 pixels) and dilated by 2 pixels to enable better visualization.
| Statistics
Data are presented as mean AE SEM. All P values were calculated by 2-tailed Student's t-test. The difference was considered to be statistically significant at the level of at least P < 0.05.
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